ClinicalTrials.gov
public full text
Public Domain
Evaluating Safety and Efficacy of ADX-914 in Patients With Moderate to Severe Atopic Dermatitis (SIGNAL-AD)
This is a phase IIa, randomized, double-blind, placebo-controlled, multi-center proof-of-concept (POC) study in subjects with moderate to severe Atopic Dermatitis.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study of IBI3033 in Moderate-to-Severe Atopic Dermatitis#878614
- Safety and Efficacy in Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis#836543
- A NOVel Moisturiser for Atopic Dermatitis: Effect on the Skin Barrier#891920
- A Phase 2 Study of CIM331 for Atopic Dermatitis Patients#864929
- Pediatric Atopic Dermatitis (AD) Internet Survey#857042
Record · ID 1281606
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive